Compounds > 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione
Page last updated: 2024-09-02

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Leukemia, Lymphocytic

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Leukemia, Lymphocytic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Culbert, S; Dicke, KA; McCredie, K; Peters, L; Spitzer, G; Verma, DS; Zander, AR1

Other Studies

1 other study(ies) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Leukemia, Lymphocytic

ArticleYear
Autologous bone marrow transplantation in acute leukemia.
    International journal of radiation oncology, biology, physics, 1979, Volume: 5, Issue:9

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Bone Marrow Transplantation; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Middle Aged; Piperazines; Radiotherapy, High-Energy; Recurrence; Remission, Spontaneous; Time Factors; Transplantation, Autologous

1979